Anti-KCNA1 antibodies are used in the immunodetection of the protein potassium voltage-gated channel subfamily A member 1. In humans, the canonical protein has a reported length of 495 amino acid residues and a mass of 56.5 kDa. Its subcellular localization is in the cytoplasmic vesicles, ER, and cell membrane. It is notably expressed in the hippocampus, cerebral cortex, and cerebellum. A member of the Potassium channel protein family, KCNA1 is known to be involved with neuronal development. Post-translational modifications have been described, including N-glycosylation, palmitoylation and phosphorylation. The KCNA1 gene has been associated with the disease, Episodic ataxia. Synonyms for this target antigen include EA1, HBK1, HUK1, KV1.1, MBK1, MK1, RBK1, and AEMK. KCNA1 gene orthologs have been reported in the mouse, rat, bovine, frog, chimpanzee and chicken species. Over 80 citations in the literature describe the use of KCNA1 antibodies in research. Western Blot is a widely used application for these antibodies. ELISA and Immunohistochemistry are also common applications.